Sign in
Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Diabetic Macular Edema: 36-Week Results From the Phase 2 BOULEVARD Clinical Trial
Rishi P. Singh, MD
Annual Meeting Talks
2018
Effect of Fluocinolone Acetonide 0.2µg/day (ILUVIEN®) Implant on the Decision to Drive in Patients With Differential Control of DME
Seenu M. Hariprasad, MD
On Demand Cases, Courses, and Papers
3-Year Update for the Phase 3 Voretigene Neparvovec-rzyl Study in Biallelic RPE65 Mutation-Associated Inherited Retinal Disease
Stephen R. Russell, MD
Category: Retinal Vascular Disease